1. a b c d e f g h i j k l m n o p q r s t u v w x y Abenavoli L, et al. Milk thistle in liver diseases: past, present, futurePhytother Res. (2010)
  2. ^ Abenavoli L, et al. Complementary therapies for treating alcoholism First Annual meeting by Complementary Medicine Research Group of the Italian Society for Alcohol Studies-May 5, 2006, Florence, ItalyFitoterapia. (2008)
  3. a b Pradhan SC, Girish C. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicineIndian J Med Res. (2006)
  4. a b c d Kroll DJ, Shaw HS, Oberlies NH. Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studiesIntegr Cancer Ther. (2007)
  5. a b c d e f Kim NC, et al. Complete isolation and characterization of silybins and isosilybins from milk thistle (Silybum marianum)Org Biomol Chem. (2003)
  6. a b Lee DY, Liu Y. Molecular structure and stereochemistry of silybin A, silybin B, isosilybin A, and isosilybin B, Isolated from Silybum marianum (milk thistle)J Nat Prod. (2003)
  7. ^ Membranes and the setting of energy demand.
  8. a b Kidd PM. Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extractsAltern Med Rev. (2009)
  9. ^ Sheu SY, Lai CH, Chiang HC. Inhibition of xanthine oxidase by purpurogallin and silymarin groupAnticancer Res. (1998)
  10. ^ Pauff JM, Hille R. Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcuminJ Nat Prod. (2009)
  11. a b Zhang S, Morris ME. Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transportJ Pharmacol Exp Ther. (2003)
  12. a b Tyagi AK, et al. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosisClin Cancer Res. (2002)
  13. ^ Maitrejean M, et al. The flavanolignan silybin and its hemisynthetic derivatives, a novel series of potential modulators of P-glycoproteinBioorg Med Chem Lett. (2000)
  14. ^ Zhou S, Lim LY, Chowbay B. Herbal modulation of P-glycoproteinDrug Metab Rev. (2004)
  15. ^ Di Pierro F, et al. Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic controlDiabetes Metab Syndr Obes. (2012)
  16. ^ Gurley BJ, et al. Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humansDrug Metab Dispos. (2006)
  17. a b Ka SO, et al. Silibinin attenuates adipogenesis in 3T3-L1 preadipocytes through a potential upregulation of the insig pathwayInt J Mol Med. (2009)
  18. ^ Goldstein JL, DeBose-Boyd RA, Brown MS. Protein sensors for membrane sterolsCell. (2006)
  19. a b c d Zhan T, et al. Silybin and dehydrosilybin decrease glucose uptake by inhibiting GLUT proteinsJ Cell Biochem. (2011)
  20. a b Nomura M, et al. Inhibitory mechanisms of flavonoids on insulin-stimulated glucose uptake in MC3T3-G2/PA6 adipose cellsBiol Pharm Bull. (2008)
  21. ^ Sonnenbichler J, Zetl I. Biochemical effects of the flavonolignane silibinin on RNA, protein and DNA synthesis in rat liversProg Clin Biol Res. (1986)
  22. a b Song Z, et al. Silymarin prevents palmitate-induced lipotoxicity in HepG2 cells: involvement of maintenance of Akt kinase activationBasic Clin Pharmacol Toxicol. (2007)
  23. ^ Salamone F, et al. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitisTransl Res. (2012)
  24. ^ Saller R, et al. An updated systematic review with meta-analysis for the clinical evidence of silymarinForsch Komplementmed. (2008)
  25. a b Jayaraj R, et al. Hepatoprotective efficacy of certain flavonoids against microcystin induced toxicity in miceEnviron Toxicol. (2007)
  26. ^ Fausto N, Campbell JS. Mouse models of hepatocellular carcinomaSemin Liver Dis. (2010)
  27. a b Brandon-Warner E, et al. Silibinin (Milk Thistle) potentiates ethanol-dependent hepatocellular carcinoma progression in male miceCancer Lett. (2012)
  28. a b Bowe WP, Patel N, Logan AC. Acne vulgaris: the role of oxidative stress and the potential therapeutic value of local and systemic antioxidantsJ Drugs Dermatol. (2012)
  29. ^ Sahib A, et al. Effects of Oral Antioxidants on Lesion Counts Associated with Oxidative Stress and Inflammation in Patients with Papulopustular AcneJ Clin Exp Dermatol Res. (2012)
  30. ^ Forinash AB, et al. The use of galactogogues in the breastfeeding motherAnn Pharmacother. (2012)
  31. ^ Low Dog T. The use of botanicals during pregnancy and lactationAltern Ther Health Med. (2009)
  32. ^ Zapantis A, Steinberg JG, Schilit L. Use of herbals as galactagoguesJ Pharm Pract. (2012)
  33. a b Di Pierro F, et al. Clinical efficacy, safety and tolerability of BIO-C (micronized Silymarin) as a galactagogueActa Biomed. (2008)